Why the study?
Obesity drives cardiovascular-kidney-metabolic syndrome, but BMI fails to reflect body fat distribution and its associated prognostic heterogeneity.
Indices reflecting peripheral-to-central adiposity provide superior prognostic value for all-cause mortality compared to BMI in individuals with early to intermediate cardiovascular-kidney-metabolic syndrome.
May refine mortality risk stratification in early CKM using fat distribution indices; leaves open incremental value over BMI in prospective studies.
Background: Cardiovascular-kidney-metabolic syndrome (CKM) is a major public health challenge. While obesity is a central driver of CKM, body mass index (BMI) fails to adequately reflect body fat distribution and its associated prognostic heterogeneity. Objectives: To evaluate the prognostic value of emerging anthropometric indices reflecting fat distribution in predicting all-cause mortality risk among individuals in the early and intermediate stages of CKM (stages 0-3). Design: A population-based retrospective cohort study utilizing data from the National Health and Nutrition Examination Survey (NHANES) 1999-2006, with mortality linkage follow-up through 2019. Methods: We analyzed 5907 adults with CKM stages 0-3. Eleven adiposity indices were evaluated using four machine learning algorithms (LASSO-Cox, RSF-Boruta, RSF, survival XGBoost) to identify key mortality predictors. Statistical analyses incorporated multivariable Cox proportional hazards regression, restricted cubic splines, false discovery rate (FDR) correction for multiple testing, and a sensitivity analysis across the entire CKM continuum (stages 0-4). Results: < 0.05). TCWR and CWR showed linear inverse trends, whereas AWR and SWR exhibited nonlinear threshold effects. These associations persisted across BMI subgroups and remained robust in the full CKM continuum subanalysis. The combined index model yielded improved discriminative ability (AUC = 0.769) compared to single indices (TCWR AUC = 0.731) and conventional BMI-based models, providing higher net clinical benefit. Conclusion: Peripheral-to-central adiposity indices are strong predictors of mortality in CKM stages 0-3, providing prognostic information beyond BMI and serving as practical tools for early risk stratification. Future studies should evaluate their dynamic changes and validate their applicability across diverse populations.
No takes yet. Share an insight, caveat, or question.
Tang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: